| [1] |
中华医学会肝病学分会、中华医学会感染病学分会. 慢性乙型肝炎防治指南(2010年版). 肝脏,2011, 16:2-16.
|
| [2] |
中华医学会传染病与寄生虫病学分会,肝病学分会. 病毒性肝炎防治方案. 中华传染病杂志,2001,19:56-62.
|
| [3] |
Lok AS,McMahon BJ. Chronic Hepatitis B: Update 2009. Hepatology, 2009, 50:661-662.
|
| [4] |
Villet S,Pichoud C,Billioud Get, et al. Impact of hepatitis B virus rtAl81V/T mutants on hepatitis B treatment failure.J Hepatol, 2008, 48:747-755.
|
| [5] |
Heathcote EJ,Marcellin P,Buti M, et al. Three-year efficacy and safty of tenofovir disoproxil fumarale treatment for chronic hepatitis B. Gastroenterology, 2011,140: 132-143.
|
| [6] |
Yuen MF, Seto WK, Fung J, et al. Three years of continuous entecavir therapy in treatment-nave chronic hepatits B patie nts: VIRAL suppression, viral resistance,and clinical safet. Am J Gastroenterol, 2011,106:1264-1271.
|
| [7] |
Chang TT, Liaw YF, Wu SS, et al. Long-termentecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological Improvement in patients with chronic hepatitis. Hepatology, 2010, 52:886-893.
|
| [8] |
Liaw YF,Sung JJ,Chow WC,et al.Lamivdine for patients with chronic hepatitis B and advanced liver disease. N Engl J Med,2004,351:1521-1531.
|
